Tonix Pharma (TNXP) Reports Q4 Loss of $2.08/Share

Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($2.08), versus ($7.96) reported last year.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Amneal gets FDA approval for lanreotide injection, launches immediately
• Faraday Future unveils nine robot models, prices start at $9,990